Carbohydrate-based cancer vaccines: target cancer with sugar bullets

  title={Carbohydrate-based cancer vaccines: target cancer with sugar bullets},
  author={Chang-Cheng Liu and Xin-Shan Ye},
  journal={Glycoconjugate Journal},
With the booming development of glycobiology and glycochemistry, more and more structures of tumor-associated carbohydrate antigens (TACAs) are identified. Their broad expression and high specificity in cancer make them important targets to develop cancer vaccines or immunotherapies. However, most of the TACAs are T cell-independent antigens, they cannot elicit a powerful enough immune response to prevent or treat cancer. Immunotolerance and immunosuppression are more easily induced due to… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 11 extracted citations


Publications referenced by this paper.
Showing 1-10 of 151 references

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine.

Proceedings of the National Academy of Sciences of the United States of America • 2012
View 4 Excerpts
Highly Influenced

Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2010
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…